PREVALENCE OF SOMATOSTATIN RECEPTOR SUBTYPE-2 IN SOMATOSTATIN RECEPTOR-POSITIVE, GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

被引：0
|
作者：
SCHERUBL, H
JOHN, M
MEYERHOF, W
RICHTER, D
WASER, B
SCHAER, JC
BOESELANDGRAF, J
NEUHAUS, P
RIECKEN, EO
REUBI, JC
WIEDENMANN, B
机构：
[1] FREE UNIV BERLIN,BENJAMIN FRANKLIN MED CTR,W-1000 BERLIN 33,GERMANY
[2] UNIV POTSDAM,DEPT GASTROENTEROL,POTSDAM,GERMANY
[3] UNIV POTSDAM,DEPT SURG,POTSDAM,GERMANY
[4] UNIV HAMBURG,MED CTR EPPENDORF,W-2000 HAMBURG 13,GERMANY
[5] UNIV BERN,DEPT PATHOL,CH-3000 BERN,SWITZERLAND
[6] FREE UNIV BERLIN,MED CTR RUDOLF VIRCHOW,DEPT SURG,W-1000 BERLIN 33,GERMANY
来源：
GASTROENTEROLOGY | 1995年 / 108卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A535 / A535
页数：1
相关论文
共 50 条
  • [1] SOMATOSTATIN-RECEPTOR IMAGING OF NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS
    SCHERUBL, H
    BADER, M
    FETT, U
    HAMM, B
    SCHMIDTGAYK, H
    KOPPENHAGEN, K
    DOP, FJ
    RIECKEN, EO
    WIEDENMANN, B
    [J]. GASTROENTEROLOGY, 1993, 105 (06) : 1705 - 1709
  • [2] NOVEL SOMATOSTATIN PEPTIDOMIMETICS AS SOMATOSTATIN RECEPTOR SUBTYPE-2 SPECIFIC IMAGING AGENTS
    Han, G.
    Kung, H. F.
    Choi, S. R.
    Makonnen, S.
    Lee, W.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S265 - S265
  • [3] Small molecule somatostatin receptor subtype-2 antagonists
    Hay, BA
    Cole, BM
    DiCapua, F
    Kirk, GW
    Murray, MC
    Nardone, RA
    Pelletier, DJ
    Ricketts, AP
    Robertson, AS
    Siegel, TW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2731 - 2734
  • [4] Is There an Additional Value of Somatostatin Receptor Subtype 2A Immunohistochemistry Over Somatostatin Receptor Scintigraphy in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
    Van Adrichem, R.
    Kamp, K.
    Van Deurzen, C.
    Biermann, K.
    Feelders, R. A.
    Kwekkeboom, D.
    Hofland, L. J.
    De Herder, W.
    [J]. NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 135 - 135
  • [5] Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
    John, M
    Meyerhof, W
    Richter, D
    Waser, B
    Schaer, JC
    Scherubl, H
    BoeseLandgraf, J
    Neuhaus, P
    Ziske, C
    Molling, K
    Riecken, EO
    Reubi, JC
    Wiedenmann, B
    [J]. GUT, 1996, 38 (01) : 33 - 39
  • [6] Antioncogenic role of somatostatin receptor subtype-2 in pancreatic cancer
    Bousquet, C
    Guillermet, J
    Saint-Laurent, N
    Fanjul, M
    Estève, JP
    Pyronnet, S
    Susini, C
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [7] Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
    Kwekkeboom, Dik J.
    Kam, Boen L.
    van Essen, Martijn
    Teunissen, Jaap J. M.
    van Eijck, Casper H. J.
    Valkema, Roelf
    de Jong, Marion
    de Herder, Wouter W.
    Krenning, Eric P.
    [J]. ENDOCRINE-RELATED CANCER, 2010, 17 (01) : R53 - R73
  • [8] Somatostatin Receptor Positron Emission Tomography: Beyond Gastroenteropancreatic Neuroendocrine Tumors
    Gagandeep Choudhary
    Samuel Galgano
    [J]. Current Radiology Reports, 7
  • [9] Somatostatin and Dopamine Receptor Profile of Gastroenteropancreatic Neuroendocrine Tumors: An Immunohistochemical Study
    Evanthia Diakatou
    Gregory Kaltsas
    Michail Tzivras
    George Kanakis
    Eugenia Papaliodi
    George Kontogeorgos
    [J]. Endocrine Pathology, 2011, 22 : 24 - 30
  • [10] Somatostatin Receptor Positron Emission Tomography: Beyond Gastroenteropancreatic Neuroendocrine Tumors
    Choudhary, Gagandeep
    Galgano, Samuel
    [J]. CURRENT RADIOLOGY REPORTS, 2019, 7 (05)
12345